Telo Genomics Balance Sheet Health
Financial Health criteria checks 4/6
Telo Genomics has a total shareholder equity of CA$590.1K and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$965.6K and CA$375.6K respectively.
Key information
0%
Debt to equity ratio
CA$0
Debt
| Interest coverage ratio | n/a |
| Cash | CA$796.02k |
| Equity | CA$590.06k |
| Total liabilities | CA$375.59k |
| Total assets | CA$965.64k |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 3D0A's short term assets (CA$919.0K) exceed its short term liabilities (CA$375.6K).
Long Term Liabilities: 3D0A has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 3D0A is debt free.
Reducing Debt: 3D0A currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 3D0A has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 3D0A has less than a year of cash runway if free cash flow continues to reduce at historical rates of 13.2% each year